A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial
Clinical trial NCT04847557 · COMPLETED
Trial details
- NCT number
- NCT04847557
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-20
- Primary completion
- 2024-07-02
- Enrollment
- 731
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.